Authors:
YUROVSKY VV
WEERSINK EJM
MELTZER SS
MOORE WC
POSTMA DS
BLEECKER ER
WHITE B
Citation: Vv. Yurovsky et al., T-CELL REPERTOIRE IN THE BLOOD AND LUNGS OF ATOPIC ASTHMATICS BEFORE AND AFTER RAGWEED CHALLENGE, American journal of respiratory cell and molecular biology, 18(3), 1998, pp. 370-383
Citation: Ss. Meltzer et al., INHIBITION OF EXERCISE-INDUCED BRONCHOSPASM BY ZILEUTON - A 5-LIPOXYGENASE INHIBITOR, American journal of respiratory and critical care medicine, 153(3), 1996, pp. 931-935
Authors:
WISNIEWSKI PL
BUSSE WW
MELTZER SS
WILLIAMS J
SHANNON T
SORKNESS C
BLEECKER ER
Citation: Pl. Wisniewski et al., BRONCHODILATORY EFFECTS OF BAYX7195, A SELECTIVE LEUKOTRIENE RECEPTORANTAGONIST, Journal of allergy and clinical immunology, 95(1), 1995, pp. 300-300
Authors:
HASDAY JD
MCCREA KA
MELTZER SS
BLEEKER ER
Citation: Jd. Hasday et al., DYSREGULATION OF AIRWAY CYTOKINE EXPRESSION IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE AND ASTHMA, American journal of respiratory and critical care medicine, 150(5), 1994, pp. 190000054-190000058
Authors:
MELTZER SS
JOHNS MA
RECHSTEINER EA
JUNGERWIRTH S
DAMICO JM
BLEECKER ER
Citation: Ss. Meltzer et al., BRONCHODILATORY EFFECTS OF BAY1005, A 5-LIPOXYGENASE INHIBITOR, IN MILD-TO-MODERATE ASTHMA, Journal of allergy and clinical immunology, 93(1), 1994, pp. 294-294
Citation: Er. Bleecker et Ss. Meltzer, BETA-AGONISTS AND ASTHMA - HOW DO NEW DEVELOPMENTS AFFECT TRADITIONALTHERAPY, The Journal of asthma, 30(3), 1993, pp. 149-154